8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
BIO-TECHNE Corp (TECH)

Bio‑Techne ($TECH) issued a press release on Feb 4, 2026 reporting results for the quarter and six months…

Filed with the SEC on · Summarized by InvestorsBot

Bio‑Techne ($TECH) issued a press release on Feb 4, 2026 reporting results for the quarter and six months ended Dec 31, 2025 and its financial condition as of Dec 31, 2025. See Exhibit 99.1 for full details. 📢📄 #BioTechne #earnings

The 8‑K attaches the Feb 4 press release as Exhibit 99.1 — the Form 8‑K itself doesn’t include the financials. Investors should review Exhibit 99.1 for revenue, EPS, cash position and any guidance. $TECH 🔎 #BioTechne #results

Note: Bio‑Techne states the info in this 8‑K and exhibits is NOT “filed” under Section 18 of the Exchange Act and isn’t incorporated by reference into other filings except where expressly stated. ⚖️ $TECH #SEC #compliance

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from BIO-TECHNE Corp

BIO‑TECHNE ($TECH) filed an 8‑K on Feb 11, 2026 disclosing an Executive Employment Agreement with Steve…

8-K · February 11, 2026

Bio‑Techne Corp filed Form 8‑K (Item 8.01) on Feb 11, 2026 — a press release was attached as Exhibit 99.1.

8-K · February 11, 2026

$TECH: Dr.

8-K · February 11, 2026

BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex.

8-K · February 4, 2026

Bio-Techne ($TECH) announced a cash dividend via press release dated Feb 4, 2026.

8-K · February 4, 2026